User profiles for N. Chomont

Nicolas Chomont

Université de Montréal
Verified email at umontreal.ca
Cited by 19973

International AIDS Society global scientific strategy: towards an HIV cure 2016

…, M Benkirane, P Cannon, N Chomont… - Nature medicine, 2016 - nature.com
Antiretroviral therapy is not curative. Given the challenges in providing lifelong therapy to a
global population of more than 35 million people living with HIV, there is intense interest in …

Immune activation and HIV persistence: implications for curative approaches to HIV infection

NR Klatt, N Chomont, DC Douek… - Immunological …, 2013 - Wiley Online Library
Despite complete or near‐complete suppression of human immunodeficiency virus ( HIV )
replication with combination antiretroviral therapy, both HIV and chronic inflammation/immune …

HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals

…, E Verdin, F Barré-Sinoussi, TW Chun, N Chomont - science, 2010 - science.org
HIV infection can persist in spite of efficacious antiretroviral therapies. Although incomplete
inhibition of viral replication may contribute to this phenomenon, this is largely due to the …

HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation

N Chomont, M El-Far, P Ancuta, L Trautmann… - Nature medicine, 2009 - nature.com
HIV persists in a reservoir of latently infected CD4 + T cells in individuals treated with highly
active antiretroviral therapy (HAART). Here we identify central memory (T CM ) and …

Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

L Trautmann, L Janbazian, N Chomont, EA Said… - Nature medicine, 2006 - nature.com
The engagement of programmed death 1 (PD-1) to its ligands, PD-L1 and PD-L2 1 , 2 , 3 , 4
, inhibits proliferation and cytokine production mediated by antibodies to CD3 (refs. 5 , 6 , 7 ). …

[HTML][HTML] Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy

…, J Watson, MH Prince, JF Hoy, N Chomont… - PLoS …, 2014 - journals.plos.org
… (A) Heatmap showing the fold change in gene expression using linear regression analysis
between CA-US HIV RNA and DEG at two hours following the initial dose of vorinostat (n = 9). …

[HTML][HTML] Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection

…, V Valcour, F Maldarelli, N Chomont, N Michael… - PloS one, 2012 - journals.plos.org
… = 5) compared to those at Fiebig I (median 8 copies/10 6 PBMCs, n = 7) AHI, p = 0.01 (Figure
5A). As more than 95% of the reservoir is harbored by CD4+ T cells (Chomont N, …

Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection

…, JP Pandey, S Mohan, N Chomont… - Science translational …, 2015 - science.org
… Participants who received VRC01 doses of 20 mg/kg (n = 3) are indicated with circular
symbols and solid lines; those who received 40 mg/kg (n = 3) are indicated with triangular …

[HTML][HTML] CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART

…, SG Deeks, SR Lewin, RP Sékaly, N Chomont - PLoS …, 2016 - journals.plos.org
HIV persists in a small pool of latently infected cells despite antiretroviral therapy (ART).
Identifying cellular markers expressed at the surface of these cells may lead to novel therapeutic …

Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection

…, TA Crowell, R Trichavaroj, R O'Connell, N Chomont… - Nature medicine, 2018 - nature.com
N. Chomont designed and performed the laboratory experiments. DJC and JA led the study,
with support from EK, JI and N. Chomchey in managing the study. JA drafted the manuscript. …